Quality of life in individuals diagnosed with larynx tumor

Ana Carolina Constantini,Carlos Takahiro Chone,Geovana Ramazzini Vechi,Vaneli Colombo Rossi

doi:10.20396/revpibic262018525

Abstract

Introduction: Malignant neoplasm of the larynx (C32), has clinical-stage depending on the tumor (T) and the region of involvement of the larynx. If the patient is assisted by the speech therapist since the pre-surgery up to the rehabilitation helps re-establishing speech communication. Evaluating the quality of life of those individuals makes it possible to understand how the chosen method of the speech rehabilitation interferes with the aspects of the life of those individuals. Objective: Analysing global and voice-related quality of life in individuals diagnosed with a laryngeal tumor. Methodology: 35 participants were invited (29 men and 6 women), all of whom were exclusively diagnosed with T3 and T4 larynx tumors. Characterization data of the sample related to the speech-language intervention were collected. In addition, the respondents answered two specific questionnaires to the quality of life: SF-36 and EORTC QLQ-C30, as well as a specific questionnaire of vocal disadvantage, was applied Voice Handicap Index. Conclusion: Results indicate that although individuals perceive little voice disadvantage, even in adverse communication conditions, the overall quality of life is greatly affected.

Highlights

Malignant neoplasm of the larynx (C32) has clinical stage depending of the tumor (T) and the region of involvement of the larynx
In the SF-36 protocol, a mean score of 93 was obtained for men and 108.53 for women, demonstrating that there is a greater perception about the vital state of the participants in the female, being well marked in all domains and in the score total, demonstrating a better quality of life for the female sex than for the male sex
Ministério da Saúde, Secretaria de Atenção à Saúde

Summary

Introduction

Malignant neoplasm of the larynx (C32) has clinical stage depending of the tumor (T) and the region of involvement of the larynx. T3 and T4 tumors present as clinical manifestation: hoarseness, pain, dysphagia, obstruction of the airways and reduced tongue mobility[1].Treatment may be surgical and / or associated radiotherapy or not to chemotherapy[2]. The speech-language pathologist is present from the pre-surgical rehabilitation, helping to reestablish communication[3].

Objectives

Results

Conclusion